“…Although several research groups have reported many clinical anomalies associated with the unfavorable progression of COVID-19, such as increases in lactate dehydrogenase, alanine aminotransferase, aspartate aminotransferase, bilirubin, creatinine, cardiac Viruses 2021, 13, 1675 2 of 16 troponin, D-dimers, procalcitonin, and C-reactive protein (CRP) [3][4][5][6], a high neutrophil-tolymphocyte ratio (NLR) has received special attention [5,7,8]. The behavior of eosinophils in a state of eosinopenia (i.e., a reduction in circulating eosinophils < 0.01 × 10 9 /L) [9], as has previously been described in response to systemic inflammation [10,11], has also been highlighted in COVID-19 [3,[12][13][14][15][16][17].…”